Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 20 de 67 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Waxmonsky JG, Pelham W 3rd, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanc T, Fallahazad N, Pelham WE 4th. A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants. J Am Acad Child Adolesc Psychiatry 2019:29 de agosto. [Ref.ID 103191]
2.Enlace a cita original Cita con resumen
Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry 2019:18 de enero. [Ref.ID 103015]
4. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
5. Cita con resumen
Anónimo. FDA approves first dronabinol solution for oral use. U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]
7. Cita con resumen
Anónimo. FDA expands approved use of Opdivo to treat lung cancer. U.S. Food and Drug Administration 2015:4 de marzo. [Ref.ID 98865]
8. Cita con resumen
Gili M, Roca M, Basu S, McKee M, Stuckler D. The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010. Eur J Public Health 2013;23:103-8. [Ref.ID 94645]
9. Cita con resumen
Kuehn BM. Off-label atypical antipsychotics. JAMA 2012;308:1198. [Ref.ID 93799]
10. Cita con resumen
Anónimo. FDA approves Cometriq to treat rare type of thyroid cancer. U.S. Food and Drug Administration 2012:29 de noviembre. [Ref.ID 93268]
11. Cita con resumen
Anónimo. Vildagliptin – a new oral antidiabetic agent. Signal 2011:13-4. [Ref.ID 91692]
12. Cita con resumen
Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. A systematic review and meta-analysis. JAMA 2011;306:1359-69. [Ref.ID 91219]
13. Cita con resumen
Anónimo. Medical marijuana. Med Lett Drugs Ther 2010;52:5-6. [Ref.ID 87932]
Treasure J, Claudino AM, Zucker N. Eating disorders. Lancet 2010;375:583-93. [Ref.ID 87837]
McKnight R, Boughton N. Anorexia nervosa. BMJ 2010;340:46-8. [Ref.ID 87672]
Attia E, Walsh BT. Behavioral management for anorexia nervosa. N Engl J Med 2009;360:500-6. [Ref.ID 85127]
17.Tiene citas relacionadas
Tremblay A, Chaput JP. About the appetite-related effects of topiramate. Eur J Clin Pharmacol 2007;63:893. [Ref.ID 80981]
18.Tiene citas relacionadas
Khazaal Y, Zullino DF. Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes. Eur J Clin Pharmacol 2007;63:891-2. [Ref.ID 80980]
19. Cita con resumen
Anónimo. Valeant gets US approval for Cesamet cannabinoid. Scrip 2006;3160:19. [Ref.ID 77062]
Yager JD, Andersen AE. Anorexia nervosa. N Engl J Med 2005;353:1481-8. [Ref.ID 74981]
Seleccionar todas
 1 a 20 de 67 siguiente >>